SRNE Sorrento Therapeutics, Inc.

$0.00

Sorrento Therapeutics, Inc. (SRNE) is expected to report earnings on October 6, 2026, after the market close.

Earnings Date
Oct 6
Tuesday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Sorrento Therapeutics, Inc.

Sorrento Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, acquisition, development and commercialization of proprietary drug therapeutics for addressing unmet medical needs in the United States.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.